HIMCH
ENTA icon

Hartford Investment Management Co (HIMCO)’s Enanta Pharmaceuticals ENTA Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,078
Closed -$218K – 572
2018
Q4 		$218K Hold
3,078
– – 0.01% 647
2018
Q3 		$263K Sell
3,078
-205
-6% -$20.5K 0.01% 648
2018
Q2 		$380K Buy
+3,283
New +$328K 0.01% 563

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s ENTA Position: Q1 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of Enanta Pharmaceuticals (ENTA) in Q1 2019, closing a stake of 3,078 shares — an estimated $218K sold.

Hartford Investment Management Co (HIMCO) first reported a position in ENTA in Q2 2018 and held it in 3 quarters. The position peaked at $380K in Q2 2018. 195 funds tracked by Wall St. Rank hold ENTA as of Q1 2019.

  • Hartford Investment Management Co (HIMCO) reported no remaining Enanta Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 3,078 Enanta Pharmaceuticals shares in Q1 2019, an estimated $218K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Enanta Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Hartford Investment Management Co (HIMCO)'s Enanta Pharmaceuticals position peaked at $380K in Q2 2018.
  • 195 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q1 2019, filed 29 Apr 2019.